{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:13:05Z","timestamp":1790745185098,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T00:00:00Z","timestamp":1367884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s11096-013-9777-9","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T07:25:05Z","timestamp":1367825105000},"page":"608-612","source":"Crossref","is-referenced-by-count":43,"title":["Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand"],"prefix":"10.1007","volume":"35","author":[{"given":"Somsak","family":"Tiamkao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukrapope","family":"Jitpimolmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittisak","family":"Sawanyawisuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthipun","family":"Jitpimolmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,7]]},"reference":[{"issue":"7","key":"9777_CR1","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-4632.2010.04481.x","volume":"49","author":"WY Ding","year":"2010","unstructured":"Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor. Malays Int J Dermatol. 2010;49(7):834\u201341.","journal-title":"Malays Int J Dermatol."},{"issue":"5","key":"9777_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"16","author":"T Harr","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;16(5):39.","journal-title":"Orphanet J Rare Dis."},{"issue":"6982","key":"9777_CR3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004;428(6982):486.","journal-title":"Nature"},{"issue":"9","key":"9777_CR4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","volume":"67","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Wang J, Zhao LM, Peng W, Shen GQ, Xue L, et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol. 2010;67(9):885\u20137.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"9777_CR5","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. 2008;49(12):2087\u201391.","journal-title":"Epilepsia."},{"issue":"5","key":"9777_CR6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","volume":"51","author":"W Tassaneeyakul","year":"2010","unstructured":"Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia. 2010;51(5):926\u201330.","journal-title":"Epilepsia."},{"issue":"12","key":"9777_CR7","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Eng J Med. 2011;364(12):1126\u201333.","journal-title":"N Eng J Med."},{"issue":"2","key":"9777_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","volume":"50","author":"CC Chang","year":"2011","unstructured":"Chang CC, Too CL, Murad S, Hussein SH. (2011) Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multiethnic Malaysian population. Int J Dermatol. 2011;50(2):221\u20134.","journal-title":"Int J Dermatol"},{"issue":"3","key":"9777_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","volume":"19","author":"XT Wu","year":"2010","unstructured":"Wu XT, Hu FY, An DM, Yan B, Jiang X, Kwan P, et al. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLAB*1502 allele among patients in central China. Epilepsy Behav. 2010;19(3):405\u20138.","journal-title":"Epilepsy Behav"},{"issue":"6","key":"9777_CR10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1399-0039.2010.01448.x","volume":"75","author":"AV Romphruk","year":"2010","unstructured":"Romphruk AV, Romphruk A, Kongmaroeng C, Klumkrathok K, Paupairoj C, Leelayuwat C. HLA\u00a0class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens. 2010;75(6):701\u201311.","journal-title":"Tissue Antigens"},{"issue":"2","key":"9777_CR11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","volume":"49","author":"P Tennis","year":"1997","unstructured":"Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology. 1997;49(2):542\u20136.","journal-title":"Neurology."},{"issue":"5","key":"9777_CR12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1528-1167.2010.02549.x","volume":"51","author":"C Locharernkul","year":"2010","unstructured":"Locharernkul C, Shotelersuk V, Hirankarn N. HLA-B* 1502 screening: time to clinical practice. Epilepsia. 2010;51(5):936\u20138.","journal-title":"Epilepsia."},{"issue":"S1","key":"9777_CR13","first-page":"S118","volume":"84","author":"N Thavichachart","year":"2001","unstructured":"Thavichachart N, Intoh P, Thavichachart T, Meksupa O, Tangwongchai S, Sughondhabirom A. Epidemiological survey of mental disorders and knowledge attitude practice upon mental health among people in Bangkok Metropolis. J Med Assoc Thai. 2001;84(S1):S118\u201326.","journal-title":"J Med Assoc Thai"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9777-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9777-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:41Z","timestamp":1559368481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9777-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["9777"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9777-9","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,7]]}}}